降压治疗的研究新动向.pptVIP

降压治疗研究新动向强化、优化和简化; 扩展降压治疗能获益的人群，当前主要聚焦在80岁以上高龄高血压患者和血压水平140/90的心血管高危患者(心、脑血管病与糖尿病)。;The results of this trial should provide reliable evidence about the effects of blood-pressure-lowering therapy in this very high-risk population. ;安慰剂;从HYVET到临床实践 ; ;HOPE 139/79 3/3 PROGRESS 147/86 9/4 EUROPA 137/82 5/2 ADVANCE 145/81 5/3 ONTARGET 142/82 6/4;; 在心血管高危患者, 强化血压控制。血压控制目标值130/80mmHg正在不断获得循证证据。;SBP;ACCORD Study Action to Control Cardiovascular risk in Diabetes;100; Adjusted relative of doubl